47 related articles for article (PubMed ID: 18451255)
1. Associations of matrix metalloproteinase-9 protein polymorphisms with lymph node metastasis but not invasion of gastric cancer.
Tang Y; Zhu J; Chen L; Chen L; Zhang S; Lin J
Clin Cancer Res; 2008 May; 14(9):2870-7. PubMed ID: 18451255
[TBL] [Abstract][Full Text] [Related]
2. Genetic polymorphisms in DPF3 associated with risk of breast cancer and lymph node metastases.
Hoyal CR; Kammerer S; Roth RB; Reneland R; Marnellos G; Kiechle M; Schwarz-Boeger U; Griffiths LR; Ebner F; Rehbock J; Nelson MR; Braun A
J Carcinog; 2005 Aug; 4():13. PubMed ID: 16109180
[TBL] [Abstract][Full Text] [Related]
3. Gene polymorphisms of cyclin-dependent kinase inhibitor and matrix metalloproteinase-9 in Sudanese patients with esophageal squamous cell carcinoma.
Eltayeb MM; Ali MM; Omar SM; Mohamed NS; Adam I; Hamdan HZ
Mol Genet Genomic Med; 2022 Dec; 10(12):e2074. PubMed ID: 36259348
[TBL] [Abstract][Full Text] [Related]
4. Association between matrix metalloproteinase-9 gene polymorphism and breast cancer in Brazilian women.
Oliveira VA; Chagas DC; Amorim JR; Pereira RO; Nogueira TA; Borges VML; Campos-Verde LM; Martins LM; Rodrigues GP; Nery Júnior EJ; Sampaio FA; Lopes-Costa PV; Sousa JMCE; Silva VC; Silva FCCD; Silva BBD
Clinics (Sao Paulo); 2020; 75():e1762. PubMed ID: 33146350
[TBL] [Abstract][Full Text] [Related]
5. Tipping the Scale Toward Gastric Disease: A Host-Pathogen Genomic Mismatch?
Tavera G; Morgan DR; Williams SM
Curr Genet Med Rep; 2018 Dec; 6(4):199-207. PubMed ID: 30775159
[TBL] [Abstract][Full Text] [Related]
6. Molecular alterations of cancer cell and tumour microenvironment in metastatic gastric cancer.
Li W; Ng JM; Wong CC; Ng EKW; Yu J
Oncogene; 2018 Sep; 37(36):4903-4920. PubMed ID: 29795331
[TBL] [Abstract][Full Text] [Related]
7. Helicobacter pylori-induced gastric pathology: insights from in vivo and ex vivo models.
Burkitt MD; Duckworth CA; Williams JM; Pritchard DM
Dis Model Mech; 2017 Feb; 10(2):89-104. PubMed ID: 28151409
[TBL] [Abstract][Full Text] [Related]
8. Matrix metalloproteinase 9 gene polymorphisms are associated with a multiple family history of gastric cancer.
Okada R; Naito M; Hattori Y; Seiki T; Wakai K; Nanri H; Watanabe M; Suzuki S; Kairupan TS; Takashima N; Mikami H; Ohnaka K; Watanabe Y; Katsuura-Kamano S; Kubo M; Hamajima N; Tanaka H;
Gastric Cancer; 2017 Mar; 20(2):246-253. PubMed ID: 27053167
[TBL] [Abstract][Full Text] [Related]
9. First evidence that Ecklonia cava-derived dieckol attenuates MCF-7 human breast carcinoma cell migration.
Kim EK; Tang Y; Kim YS; Hwang JW; Choi EJ; Lee JH; Lee SH; Jeon YJ; Park PJ
Mar Drugs; 2015 Mar; 13(4):1785-97. PubMed ID: 25830682
[TBL] [Abstract][Full Text] [Related]
10. Prognostic and clinical significance of STAT3 and MMP9 in patients with gastric cancer: a meta-analysis of a Chinese cohort.
Chen J; Liu X; Jiao H; Peng L; Huo Z; Yang W; Shen Q; Li T; Liu Q
Int J Clin Exp Med; 2015; 8(1):546-57. PubMed ID: 25785029
[TBL] [Abstract][Full Text] [Related]
11. Matrix metalloproteinases and gastrointestinal cancers: Impacts of dietary antioxidants.
Verma S; Kesh K; Ganguly N; Jana S; Swarnakar S
World J Biol Chem; 2014 Aug; 5(3):355-76. PubMed ID: 25225603
[TBL] [Abstract][Full Text] [Related]
12. cDNA-microarray analysis as a new tool to predict lymph node metastasis in gastric cancer.
Ojetti V; Persiani R; Cananzi FC; Sensi C; Piscaglia AC; Saulnier N; Biondi A; Gasbarrini A; D'Ugo D
World J Surg; 2014 Aug; 38(8):2058-64. PubMed ID: 24696059
[TBL] [Abstract][Full Text] [Related]
13. Gelatinase B/MMP-9 in Tumour Pathogenesis and Progression.
Farina AR; Mackay AR
Cancers (Basel); 2014 Jan; 6(1):240-96. PubMed ID: 24473089
[TBL] [Abstract][Full Text] [Related]
14. XB130 promotes proliferation and invasion of gastric cancer cells.
Shi M; Zheng D; Sun L; Wang L; Lin L; Wu Y; Zhou M; Liao W; Liao Y; Zuo Q; Liao W
J Transl Med; 2014 Jan; 12():1. PubMed ID: 24387290
[TBL] [Abstract][Full Text] [Related]
15. Functional polymorphisms of matrix metalloproteinase-9 and survival in patients with locoregionally advanced nasopharyngeal carcinoma treated with chemoradiotherapy.
Liu H; Huang PY; Tang LQ; Chen QY; Zhang Y; Zhang L; Guo L; Luo DH; Mo HY; Xiang YQ; Qiu F; Sun R; Chen MY; Hua YJ; Lv X; Wang L; Zhao C; Guo X; Cao KJ; Qian CN; Hong MH; Mai HQ
Med Oncol; 2013 Dec; 30(4):685. PubMed ID: 23955812
[TBL] [Abstract][Full Text] [Related]
16. MMP-9 polymorphisms are related to serum lipids levels but not associated with colorectal cancer susceptibility in Chinese population.
Yang ZH; Li SN; Liu JX; Guo QX; Sun XW
Mol Biol Rep; 2012 Oct; 39(10):9399-404. PubMed ID: 22729913
[TBL] [Abstract][Full Text] [Related]
17. Expression of Krűppel-like factor 5 in gastric cancer and its clinical correlation in Taiwan.
Soon MS; Hsu LS; Chen CJ; Chu PY; Liou JH; Lin SH; Hsu JD; Yeh KT
Virchows Arch; 2011 Aug; 459(2):161-6. PubMed ID: 21732124
[TBL] [Abstract][Full Text] [Related]
18. Single-nucleotide polymorphisms of matrix metalloproteinases and their inhibitors in gastrointestinal cancer.
Langers AM; Verspaget HW; Hommes DW; Sier CF
World J Gastrointest Oncol; 2011 Jun; 3(6):79-98. PubMed ID: 21731908
[TBL] [Abstract][Full Text] [Related]
19. Bioinformatic analyses identifies novel protein-coding pharmacogenomic markers associated with paclitaxel sensitivity in NCI60 cancer cell lines.
Eng L; Ibrahim-zada I; Jarjanazi H; Savas S; Meschian M; Pritchard KI; Ozcelik H
BMC Med Genomics; 2011 Feb; 4():18. PubMed ID: 21314952
[TBL] [Abstract][Full Text] [Related]
20. Matrix Metalloproteinase-9 (MMP9)-A Mediating Enzyme in Cardiovascular Disease, Cancer, and Neuropsychiatric Disorders.
Rybakowski JK
Cardiovasc Psychiatry Neurol; 2009; 2009():904836. PubMed ID: 20037727
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
